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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌto 
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation  
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3 Population and Healthcare Overview 
The population of Sweden is 10,067,744 (World Bank, 2018a) and birth rate is estimated at 
11.8 births/1,000 population in 2016 (World Bank, 2018b). The change in population and 
birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Sweden has a reported population density of 25 people per square kilometre in 2017 and 
this has risen from 18 people per square kilometre in 1961 (World Bank, 2018c). Infant 
mortality in 2017 is estimated at 2.3 deaths/1,000 live births in total (World Bank, 2018d). 
The average life expectancy in Sweden is estimated at 82.2 years (World Bank, 2018e), with 
a death rate 9.2 deaths/1,000 population in 2016 (World Bank, 2018f). Sweden has a gross 
national income per capita (PPP int. $, 2013) of $44,000 (WHO, 2016b). The estimated total 
expenditure on health per capita in 2014 was $5,219 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 11.9% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in Sweden between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
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4 Vision Screening Commissioning and Guidance 
Vision screening in Sweden is organised regionally in all twenty regions. All regions deliver 
vision screening, but operate using different referral criterion. Vision screening is funded by 
each region and is embedded into a general preventative child healthcare screening system.  
 The information provided for this report is based upon the service provision in Sahlgrenska 
Akademin in region of Gothenburg.  
The vision screening programme began in 1968 and was implemented across Sweden in 1973. 
There have been the following changes since its implementation: 
x The referral criteria which once stated that the nurse should refer 4-year old children 
with visual acuity less than 0.8 decimal (0.1 logMAR, 6/7.5 Snellen) in each eye, and 5-
year old children with visual acuity less than 1.0 decimal (0.0 logMAR, 6/6 Snellen) in 
each eye. These referral criteria have been withdrawn.  
x The vision charts used in each area. Gothenburg and surrounding areas (with about 
1.5 million inhabitants) continue to use HOTV-charts but in some parts of Sweden Lea 
symbols charts are used.  
There are regional general health screening guidelines which include vision screening. There 
is no defined review process of the vision screening programmes, therefore they are not 
regularly reviewed or changed. There are no methods for quality monitoring imposed by the 
government.  
In Sweden, vision screening is conducted by ophthalmologists, paediatricians, general 
practitioners (GP) or specialist nurses in either a school, hospital or child healthcare centres 
depending on the age group. It is not known how many vision screening professionals there 
are for every million people and no general professionals have been identified that do not 
screen, but could do so with additional training. There is no specific training currently 
available to perform vision screening in Sweden.  
There has been research carried out concerning the vision screening programme in Sweden, 
including the clinical effectiveness of the vision screening programme, Gyllencreutz et al., 
2018; Hard, 2007; Hard et al., 2002; Kvarnström & Jakobsson, 2005; Kvarnström et al., 1998. 
There has been no cost-effectiveness analysis.  
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5 Screening programme  
Amblyopia is the target condition screened for in Sweden. The health care professionals 
delivering vision screening, venue for screening and tests used vary depending on the age of 
the child as shown in Tables 1, 2 and 3 respectively. Specific details of the screening offered 
within each age group are described more fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies, born 36 weeks gestational age or earlier, are screened by either an 
ophthalmologist within a hospital, if they are. The vision screening tests utilised for preterm 
babies include only retinal examination.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies aged up to 3 months are screened by either a paediatrician or GP in 
hospital or a child healthcare centre. The vision screening tests utilised include eye inspection, 
fixation, red reflex testing and pupillary reflexes. Red reflex testing and eye inspection are 
carried out at birth. At the age of 4-6 weeks, red reflex testing is repeated along with pupillary 
reflexes, eye inspection and fixation. Babies are immediately referred to an ophthalmologist 
for further examination if disease is suspected, such as cataract or retinoblastoma.  
5.3 Vision screening - 3 months to 36 months 
Babies aged 3 to 36 months are screened three times by a GP or a specialist nurse in a child 
healthcare centre. This is carried out at 6 months, 10 to 12 months, and 18 months of age. 
The vision screening tests utilised at these ages are eye inspection, fixation, eye motility and 
Hirschberg test. Referral for further diagnostic examination is made to an ophthalmologist 
after a maximum of two inconclusive or abnormal screening test results. Whether it is one or 
two screening tests administered before referral is determined based on the clinical 
judgement of the specialist nurse conducting the screening.  
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months to 7 years are screened twice by a specialist nurse. At the age of 4 
years, vision screening is carried out in child healthcare centres. At the age of 6 to 7 years, 
vision screening is carried out in schools. The vision screening test utilised is a visual acuity 
measurement, this is conducted for the first time at 4 years of age (a re-test is conducted at 
5 years of age if the result at 4 years is not acceptable) and then once more at the age of 6 to 
7 years. The optotype charts used to measure visual acuity include Lea Symbols (LH), 
Konstantin Moutakis (KM) and HOTV, all of which are linear, crowded charts with a range of 
0.1 to 1.0 (decimal). At 4 and 5 years of age, HOTV or LH are recommended in the national 
guidelines. The referral criteria is decided regionally, and there are no national guidelines for 
screening school children. In the Gothenburg region, KM-chart is recommended but some 
Summary Vision Screening Data: Sweden                                                                                         
 
5 
 
schools in the region still use old E-charts. Referral for further diagnostic examination is made 
to an ophthalmologist after a maximum of two inconclusive or two abnormal screening test 
results. Whether it is one or two screenings is determined based on the clinical judgement of 
the specialist nurse conducting the screening.  
The referral criteria is: 
x At 4 years using HOTV =  < 0.8 decimal (0.1 logMAR, 6/7.5 Snellen) in each eye. But if 
the child has VA of 0.65 decimal (0.2 logMAR, 6/9.5 Snellen) in one or both eyes they 
are retested at 5 years before referral.  
x At 6-7 years using KM  = < 0.8 decimal (0.1 logMAR, 6/7.5 Snellen) in both eyes.  
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 
Paediatrician Specialist nurse Ophthalmologist GP 
Preterm babies  × × 9 × 
0 to 3 months  9 × × 9 
3 to 36 months  × 9 × 9 
3 to 7 years  × 9 × × 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
Eye 
inspection 
Fixation Red reflex 
testing 
Eye 
motility 
Hirschberg Retinal 
examination 
Pupillary 
reflexes 
Visual acuity 
measurement 
Preterm babies  × × × × × 9 × × 
0 to 3 months  9 9 9 9 × × 9 × 
3 to 36 months  × × 9 9 × × × × 
3 to 7 years  × × × × × × × 9 
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Table 3: Location of vision screening for each age group  
Table 3 
Hospital School Child Healthcare Centre 
Preterm babies  9 × × 
0 to 3 months  9 × 9 
3 to 36 months  × × 9 
3 to 7 years  × 9 9 
 
 
Summary Vision Screening Data: Sweden                                                                                         
 
9 
 
6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss. No 
automated vision screening is conducted in Sweden.  
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7 Provision for Visually Impaired  
In Sweden, there is one school for blind or severely visually impaired children. There is special 
support for visually impaired children who attend mainstream primary school, but it is not 
clear what this support is. The costs per child are not known.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
The prevalence of amblyopia was found to be 0.7% in a sample of 143 children aged 4-15 
years of age (Grönlund et al., 2006). The prevalence of untreated and persistent amblyopia 
by the age of 7 years, is estimated as 0.2% (Grönlund et al., 2006) The prevalence of 
strabismus is estimated at 3.5% (Grönlund et al., 2006) There is no available data concerning 
the incidence of the four types of amblyopia (strabismic, refractive, combined mechanism 
and deprivation).   
8.2 Coverage 
All children are invited for vision screening; this is sent out in the form of a letter by the child 
healthcare centres. The coverage for all vision screening programmes before the age of 7 
years is estimated at 99%. At the Institute of Neuroscience and Physiology Sahlgrenska 
Akademin in Gothenburg, all referrals are registered and if the child does not attend the 
examination, the parents are contacted until the child gets an examination. This intervention 
has created 100% compliance, although this procedure and uptake may differ within the 
country.  
8.3 Screening evaluation 
Data has been provided from the study by Kvarnström et al (1998) which found false positive 
referral across 5 regions in Sweden to average 29.0% and false negatives to average 5.7% (N= 
3,126). The sensitivity of vision screening is determined based on age:  
x 4 years of age: Sensitivity - 86.2%; Specificity - 97.7% 
x 5.5 years of age: Sensitivity - 88.6%; Specificity - 98.6% 
x 4 and 5.5. years of age: Sensitivity - 91.4%; Specificity - 96.9% 
x 6-years of age: Sensitivity - 97.8%; Specificity - 99.4% 
8.4 Treatment success 
All eligible children are offered treatment. There is no data available concerning the 
percentage of infants treated for congenital eye disorders, or strabismus. It is not known how 
many patients are treated for congenital cataract, amblyopia and strabismus per year by 
orthoptists and/or ophthalmologists. 
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The salary costs per year and per hour for vision screening professionals cannot be calculated. 
There is no available data regarding how much it costs to train the general preventative child 
healthcare screening professionals between leaving secondary education to qualification. It 
is not known what the total screening costs per year for vision screening are in Sweden. It is 
not known what the total costs per child per year for vision screening are nationally or 
regionally.  
9.2 Cost of treatment for amblyopia 
It is not known what the estimated screening costs are for treatment of typical patients with 
refractive amblyopia and strabismic amblyopia, including follow-up.  
9.3 Cost of Treatment for strabismus  
 It is not known what the estimated costs or strabismus surgery are, including follow-up. 
9.4 Cost of treatment for cataract 
It is not known what the estimated costs for congenital cataract surgery, including follow-up 
of deprivation amblyopia.  
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